Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Pharm Res. 2013 Jan 15;30(5):1240–1251. doi: 10.1007/s11095-012-0963-6

Figure 8.

Figure 8

Average concentration versus time of CA-lys-TFA after oral administration of 50 mg/kg CA-lys-TFA. Panel A shows CA-lys-TFA concentration in gallbladder, liver, and plasma. CA-lys-TFA in gallbladder was generally over 500-fold higher than in liver or plasma. Panel B slows an expanded plot, to better visualize the lower concentrations in liver and plasma.